...
首页> 外文期刊>Bioorganic and medicinal chemistry >Novel 6-methanesulfonamide-3,4-methylenedioxyphenyl-N-acylhydrazones: orally effective anti-inflammatory drug candidates.
【24h】

Novel 6-methanesulfonamide-3,4-methylenedioxyphenyl-N-acylhydrazones: orally effective anti-inflammatory drug candidates.

机译:新型6-甲磺酰胺-3,4-亚甲二氧基苯基-N-酰基hydr:口服有效的抗炎药候选物。

获取原文
获取原文并翻译 | 示例
           

摘要

We described herein the molecular design of novel in vivo anti-inflammatory 6-methanesulfonamide-3,4-methylenedioxyphenyl-N-acylhydrazone derivatives (1) planned by applying the molecular hybridization approach. This work also points out to the discovery of LASSBio-930 (1c) as a novel anti-inflammatory and anti-hyperalgesic prototype, which was able to reduce carrageenan-induced rat paw edema with an ED(50) of 97.8 micromol/kg, acting mainly as a non-selective COX inhibitor.
机译:我们在本文中描述了通过应用分子杂交方法计划的新型体内抗炎性6-甲磺酰胺-3,4-亚甲二氧基苯基-N-酰基hydr衍生物的分子设计。这项工作还指出了LASSBio-930(1c)作为一种新型消炎和抗痛觉过敏原型的发现,该原型能够以97.8 micromol / kg的ED(50)减少角叉菜胶诱发的大鼠爪水肿,主要充当非选择性COX抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号